747 results on '"Akre, Olof"'
Search Results
2. Assessing the Impact of Positive Surgical Margins on Mortality in Patients Who Underwent Robotic Radical Prostatectomy: 20 Years’ Report from the EAU Robotic Urology Section Scientific Working Group
3. Prostate Cancer–specific and All-cause Mortality After Robot-assisted Radical Prostatectomy: 20 Years’ Report from the European Association of Urology Robotic Urology Section Scientific Working Group
4. ASO Author Reflections: Arterial Ischemic Events Following Cancer Surgery: Where Do We Stand?
5. Primary Retroperitoneal Lymph Node Dissection as Treatment for Low-volume Metastatic Seminoma in a Population-based Cohort: The Swedish Norwegian Testicular Cancer Group Experience
6. Prediagnostic Prostate-specific Antigen Testing and Clinical Characteristics in Men with Lethal Prostate Cancer
7. Population-based Organised Prostate Cancer Testing: Results from the First Invitation of 50-year-old Men
8. AI Support for Accelerating Histopathological Slide Examinations of Prostate Cancer in Clinical Studies
9. MP77-11 NOMOGRAM PREDICTING OPTIMAL CANDIDATES FOR BLADDER-SPARING STRATEGIES AFTER NEOADJUVANT IMMUNOTHERAPY
10. MP14-02 IDENTIFY THE OPTIMAL CANDIDATES FOR ADJUVANT ANDROGEN DEPRIVATION THERAPY AMONG PATIENTS WITH DETECTABLE PSA AFTER RADICAL PROSTATECTOMY
11. PD29-12 THE IMPACT OF THE TIME ELAPSED BETWEEN PRIMARY TREATMENT AND BCR ON CANCER SPECIFIC MORTALITY IN PATIENTS WHO EXPERIENCED BCR AFTER PRIMARY TREATMENT
12. Characteristics of Patients in SPCG-15—A Randomized Trial Comparing Radical Prostatectomy with Primary Radiotherapy plus Androgen Deprivation Therapy in Men with Locally Advanced Prostate Cancer
13. Systematic review and meta-analysis: relationships between attention-deficit/hyperactivity disorder and urinary symptoms in children
14. Long‐term oncological outcomes after multimodal treatment for locally advanced prostate cancer.
15. Long-Term Oncological Outcomes after Nerve-Sparing Robot-Assisted Radical Prostatectomy for High-Risk Localized Prostate Cancer: A Single-Center, Two-Arm Prospective Study
16. Risk of Venous Thromboembolic Events After Surgery for Cancer
17. Urinary continence recovery and oncological outcomes after surgery for prostate cancer analysed by risk category: results from the LAParoscopic prostatectomy robot and open trial
18. Risk of Recurrent Disease 6 Years After Open or Robotic-assisted Radical Prostatectomy in the Prospective Controlled Trial LAPPRO
19. Sex Differences in Urothelial Bladder Cancer Survival
20. Risk of Postoperative Ischemic Stroke and Myocardial Infarction in Patients Operated for Cancer
21. Assessing the Impact of Positive Surgical Margins on Mortality in Patients Who Underwent Robotic Radical Prostatectomy: 20 Years’ Report from the EAU Robotic Urology Section Scientific Working Group
22. Risk of esophageal and gastric adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer
23. COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial
24. Interchangeability of light and virtual microscopy for histopathological evaluation of prostate cancer
25. Time-to-event Outcomes in Men with Nonmetastatic Castrate-resistant Prostate Cancer—A Systematic Literature Review and Pooling of Individual Participant Data
26. Cohort profile: the Turin prostate cancer prognostication (TPCP) cohort
27. Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy
28. Prostate Cancer–specific and All-cause Mortality After Robot-assisted Radical Prostatectomy: 20 Years’ Report from the European Association of Urology Robotic Urology Section Scientific Working Group
29. Oncologic Outcomes After Robot-assisted Radical Prostatectomy: A Large European Single-centre Cohort with Median 10-Year Follow-up
30. Preoperative staging using magnetic resonance imaging and risk of positive surgical margins after prostate-cancer surgery
31. Increased Risk for Cardiovascular Mortality in Psoriasis Inpatients but Not in Outpatients
32. Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer
33. Supplemental Table 1 from Cannabis Use and Incidence of Testicular Cancer: A 42-Year Follow-up of Swedish Men between 1970 and 2011
34. Supplementary Figure 1 from Subtype-Specific Risk of Testicular Tumors among Immigrants and Their Descendants in Sweden, 1960 to 2007
35. Data from Cannabis Use and Incidence of Testicular Cancer: A 42-Year Follow-up of Swedish Men between 1970 and 2011
36. Supplementary Table 1 from Subtype-Specific Risk of Testicular Tumors among Immigrants and Their Descendants in Sweden, 1960 to 2007
37. Supplementary Figure Legend from Subtype-Specific Risk of Testicular Tumors among Immigrants and Their Descendants in Sweden, 1960 to 2007
38. Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy
39. DNA methylation in repeat negative prostate biopsies as a marker of missed prostate cancer
40. Quantity and quality of nucleic acids extracted from archival formalin fixed paraffin embedded prostate biopsies
41. Acquired Hypothyroidism as a Predictive Marker of Outcome in Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors: A Literature-Based Meta-Analysis
42. Cardiovascular, bone, and metabolic health in men with castrate-resistant prostate cancer treated with androgen deprivation: a matched cohort study
43. Effect of digital-enabled multidisciplinary therapy conferences on efficiency and quality of the decision making in prostate cancer care
44. Nationwide, population‐based study of post radical prostatectomy urinary incontinence correction surgery
45. Authors’ reply to Roach
46. Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer : observational study of mortality outcomes
47. Travel vaccines are strongly associated to reduced mortality in prostate cancer patients - a real effect or residual confounding?
48. Increased Risk of Barrett's Esophagus Among Individuals Born Preterm or Small for Gestational Age
49. How can we make cancer survival statistics more useful for patients and clinicians: An illustration using localized prostate cancer in Sweden
50. Obstructive pulmonary disease in old age among individuals born preterm
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.